Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  lomustine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 253 for your search:
Start Over
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9802, CDR0000066367, E-R9802, NCCTG-R9802, SWOG-R9802, RTOG-DEV-1012, NCT00003375
Phase II-III Chemotherapy with ADR/VCR/ARA-C plus Immunotherapy with BCG and Irradiated Cells for Acute Myelogenous Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: EORTC-LAM-4
Phase III Randomized, Placebo-Controlled Study of CCNU with vs without Benznidazole in Patients with Malignant Glioma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: MRC-BR03, EU-94010
Phase III Randomized Study of Radiotherapy with vs without BUDR and Followed by PCV (PCB/CCNU/VCR) for Anaplastic Astrocytomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9404, NCCTG-947251, SWOG-9340, RTOG-94-04
Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9402, CDR0000063603, CAN-NCIC-CE2, E-R9402, NCCTG-927252, SWOG-9402, INT-0149, CE2, NCT00002569
Phase III Randomized Study of Sequential vs Alternating Radiotherapy and CTX/MTX/CCNU for Limited Stage Small Cell Lung Cancer (Summary Last Modified 10/94)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: MRC-LU04, EU-94019
Phase III Chemohormonal Therapy with ADR/CCNU/VCR/FXM vs CTX/MPA plus Immunotherapy with C. parvum for Metastatic Renal Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 70
Sponsor:
Protocol IDs: MSHMC-REN-2
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 to 69
Sponsor: Other
Protocol IDs: EORTC-26951, MRC-BR11, NCT00002840
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 3 to 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: A9961, CCG-A9961, POG-A9961, CDR0000065160, NCT00002875
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 10
Sponsor: NCI, Other
Protocol IDs: A9952, CCG-A9952, POG-A9952, CCG-9952, CDR0000065394, COG-A9952, NCT00002944
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9813, CDR0000067512, ECOG-R9813, NCCTG-RTOG-9813, NCT00004259
Phase III Study of Chemotherapy with ADR/CCNU/HMM/MTX and Amphotericin B for Advanced non-Small Cell Bronchogenic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CHNMC-COH-CA-LUN-1, NCI-D80-035-131
Phase III Chemotherapy with IPP, IPP/ADR and CIA (IPP/ADR/CCNU) for Extensive non-Oat Cell Lung Carcinoma (Summary last modified 06/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7701
Phase III Chemotherapy with CAVP (CTX/ADR/VCR/PRED) vs CVP (CTX/VCR/PRED) for Disseminated non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7312A
Phase III Study of CCNU Versus CCNU plus Vincristine for Disseminated Malignant Melanoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WCG-119
Phase III Chemotherapy with CTX/VCR/PRED vs VCR/PRED/CCNU for Remission Induction in non-Hodgkin's Lymphomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WCG-120
Phase III Evaluation of Chemotherapy with MOPP vs Chemotherapy with CCNU/VBL/PRED for Adult Advanced Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: WCG-130
Phase III Adjuvant Radiotherapy and Chemotherapy with CCNU/MTX/ADR for Stages I and II Bronchogenic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: WFU-62277
Phase III Reinduction with ARA-C/DNM vs CYC/DNM and Maintenance with ARA-C/CTX vs CYC/CTX for Acute Nonlymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 20
Sponsor: NCI
Protocol IDs: CCG-243
Phase III CVPP (CCNU/VBL/PCB/PRED) Alone or in Combination with Involved or Extended Field Radiotherapy for Stage I/II Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 16
Sponsor: NCI
Protocol IDs: CLB-7751
Start Over